February, 2025
February 2025
M T W T F S S
 12
3456789
10111213141516
17181920212223
2425262728  
Insights from The Lymphoma, Leukemia and Myeloma Winter Symposium
Feb 12, 2025, 07:49

Insights from The Lymphoma, Leukemia and Myeloma Winter Symposium

The inaugural LL&M Winter Symposium, a flagship event of the Lymphoma, Leukemia & Myeloma Congress, was held from February 7–9, 2025, in Miami, USA.

Home | LL&M Winter Symposium

Our team at OncoDaily has compiled a list of highlights you should not miss from the event:

Joanna M. Rhodes:

“Had a great time presenting at the inaugural LLM Winter this week with friends and colleagues! Exciting to have participated in a panel with Andrew Evens!”

Yan Leyfman:

“Great presentation about BTKi and BCL2 Therapy from Global Leader, Dr. Jacqueline Claudia Barrientos of Mount Sinai Medical Center of Florida at the 2025 Lymphoma, Leukemia & Myeloma Congress Winter Symposium.”

Image preview

Mikkael Sekeres:

With the Myeloid Mafia ⁩in Miami! Great meeting and amazing education!”

LL&M Winter Symposium

“We had a great panel of speakers last night discussing Research and Clinical Advances in the Leukemia Landscape. Looking forward to more insightful sessions all day today and tomorrow. Explore the agenda here.

Featured: Drs. Sangeetha Venugopal, Gail Roboz, Kristen O’Dwyer, Gabriela Hobbs, and Mikkael Sekeres.

Image preview

Fadi Haddad:

Great time spent at the LLM 2025 meeting.

  • Up-to-date presentations on leukemia and hematologic malignancies with clinical implications
  • Connecting with friends and colleagues – Sangeetha Venugopal, Rami Komrokji and Mikkael Sekeres
  • Enjoying the sun of Miami”

Insights from The Lymphoma, Leukemia and Myeloma Winter Symposium

Mateo Mejia:

“Dr. Diamond with a great update on Ententamig and the potential advantage of its bivalent design.”

Image

Andrew M. Evens:

Joanna M. Rhodes with a great talk on optimized therapy for frontline high tumor burden follicular lymphoma at the Miami LLMWinter25. Many ongoing clinical trials with the integration of targeted agents to improve outcomes (including HRQL)!”

Image

Keep up with the next event by the Lymphoma, Leukemia & Myeloma Congress here.